|
PELI1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.61349999999927E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.53319999976576E-07 |
| Normal-vs-Stage2 |
8.580400E-03 |
| Normal-vs-Stage3 |
4.095600E-03 |
| Normal-vs-Stage4 |
5.679500E-02 |
| Stage1-vs-Stage2 |
2.063200E-01 |
| Stage1-vs-Stage3 |
1.893560E-02 |
| Stage1-vs-Stage4 |
1.259480E-03 |
| Stage2-vs-Stage3 |
6.811600E-01 |
| Stage2-vs-Stage4 |
2.183200E-01 |
| Stage3-vs-Stage4 |
2.993000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.4187999999925E-05 |
| Normal-vs-AfricanAmerican |
6.136800E-03 |
| Normal-vs-Asian |
3.429600E-02 |
| Caucasian-vs-AfricanAmerican |
6.307600E-01 |
| Caucasian-vs-Asian |
6.080600E-01 |
| AfricanAmerican-vs-Asian |
5.295600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.576630E-04 |
| Normal-vs-Female |
2.5704999995213E-07 |
| Male-vs-Female |
1.474270E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.101600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.04879999995866E-06 |
| Normal-vs-Age(61-80Yrs) |
3.770100E-04 |
| Normal-vs-Age(81-100Yrs) |
4.600000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.242400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.961200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.004800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.094400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.194400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.766400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.07070000000287E-05 |
| Normal-vs-Grade 2 |
4.71850003513907E-09 |
| Normal-vs-Grade 3 |
6.433300E-04 |
| Normal-vs-Grade 4 |
1.732760E-01 |
| Grade 1-vs-Grade 2 |
2.680000E-01 |
| Grade 1-vs-Grade 3 |
9.354800E-04 |
| Grade 1-vs-Grade 4 |
1.797230E-03 |
| Grade 2-vs-Grade 3 |
3.89350000000732E-05 |
| Grade 2-vs-Grade 4 |
1.448140E-04 |
| Grade 3-vs-Grade 4 |
1.620410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.12820025228211E-10 |
| Normal-vs-ccB subtype |
3.499800E-03 |
| ccA subtype-vs-ccB subtype |
2.231600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.58319999999224E-05 |
| Normal-vs-N1 |
1.755010E-01 |
| N0-vs-N1 |
9.050000E-01 |
|
|
